Year: 2024
Type: dissertation
Abstract: The Hippo signaling pathway is a master regulator of tissue growth. When the pathway is inactivated, the Hippo transcriptional mediators YAP/TAZ induce a pro-tumorigenic transcriptional program. The Hippo pathway is frequently dysregulated in cancer, making it an attractive target for therapeutic intervention, however the limited availability of druggable pathway components poses a challenge. A recent CRISPR screen of bladder and breast cancer cells conducted in our lab identified the liprin, PPFIA1, as an upstream modulator of Hippo signaling. PPFIA1 is frequently amplified and displays high expression levels in head and neck squamous cell carcinomas (HNSCCs), leading to poor prognoses for those patients. Here, I assessed the effects of PPFIA1 loss on Hippo pathway activity and on the tumorigenic properties of several HNSCC cell lines. I found that abrogation of PPFIA1 expression results in a decrease in YAP/TAZ target gene expression and hindered cell growth and migration. Overall, these findings provide valuable insights into a prospective mechanistic avenue for therapeutic intervention in the seventh most prevalently diagnosed cancer worldwide.
Source: TSpace (University of Toronto)
Author: Winn, Jamie K
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7225766562
